Overexpression of catalytic subunit M2 in patients with ovarian cancer

Li-Ming WANG; Fei-Fei LU; Shao-Yan ZHANG; Ru-Yong YAO; Xiao-Ming XING; Zhi-Min WEI.
Chinese Medical Journal ; (24): 2151-2156, 2012.
Artículo en Inglés | WPRIM | ID: wpr-244396

Documentos relacionados

  1. Overexpression of catalytic subunit M2 in patients with ovarian cancer.
  2. [Expression of Ribonucleotide Reductase M2 in Patients with Multiple Myeloma and Its Mechanism Inhibiting Tumor Cell Proliferation].
  3. Critical role for ribonucleoside-diphosphate reductase subunit M2 in ALV-J-induced activation of Wnt/ß-catenin signaling via interaction with P27.
  4. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
  5. Circ_0008285 knockdown represses tumor development by miR-384/RRM2 axis in hepatocellular carcinoma.
  6. Identification of RRM2 as a key ferroptosis-related gene in sepsis.
  7. Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells.
  8. ARID1A promotes chemosensitivity to gemcitabine in pancreatic cancer through epigenetic silencing of RRM2.
  9. Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
  10. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis.